About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,340 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,340 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 281-300 of 3,340 trials

CompletedVaccine Therapy in Treating Patients With Metastatic MelanomaRATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill tumor cells.NCT00019734·Bethesda, Maryland UnknownInterferon Alfa Following Surgery in Treating Patients With Stage III MelanomaRATIONALE: Interferon alfa may interfere with the growth of the cancer cells.NCT00006249·East Melbourne, Victoria and 103 others

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

Active not recruitingLiquid Biomarker Study in Melanoma and Non-Melanoma Skin CancersThe goal of this observational study is to study blood samples and compare them to other biospecimens and clinical outcomes in participants who have melanoma or non-melanoma skin…NCT06608511·Madison, Wisconsin

AvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesThe objective of this expanded access program is to provide ulixertinib (BVD-523) for compassionate use in advanced cancer patients with MAPK pathway-altered solid tumor(s)…NCT04566393·Mobile, Alabama and 25 others

CompletedTicilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV MelanomaRATIONALE: Monoclonal antibodies, such as ticilimumab (CP-675,206), can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00471887·Los Angeles, California

RecruitingA Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called cemiplimab (also known as REGN2810), called…NCT06246916·Chandler, Arizona and 111 others

CompletedA Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic MelanomaTo evaluate the safety of intratumorally injected VCL-IM01 at doses of 0.5 mg (1 tumor), 1.5 mg (1 tumor), 5 mg (1 tumor), 10 mg (2 tumors, 5 mg per tumor) and 15 mg (3 tumors, 5…NCT00223899·Mobile, Alabama and 3 others

TerminatedFive Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient OutcomesThe EXPAND Registry Study follows patients with cutaneous melanoma who have had the DecisionDx-Melanoma gene expression assay performed as part of their clinical care.NCT02355587·Santa Rosa, California and 3 others

CompletedHu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced MelanomaRATIONALE: Biological therapies, such as hu14.18-interleukin-2 fusion protein, may stimulate the immune system in different ways and stop tumor cells from growing.NCT00109863·Madison, Wisconsin

CompletedBiomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib TosylateRATIONALE: Studying samples of tissue in the laboratory from patients receiving carboplatin and paclitaxel with or without sorafenib tosylate may help doctors learn more about the…NCT01209299

UnknownHarmonics-based in Vivo Optical Virtual BiopsyThe research aims to study the molecules and structures in human skin by the image formation of harmonic-based in vivo optical virtual biopsy.NCT01980264·Taipei

CompletedA Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersThis is a study of CDX-1127, a therapy that targets the immune system and may act to promote anti-cancer effects.NCT01460134·Scottsdale, Arizona and 9 others

RecruitingEfficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint BlockadeThis study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies combined with bevacizumab and metronomic cyclophosphamide in patients with metastatic non-small cell…NCT07130032·Saint Petersburg, Sankt-Peterburg

Active not recruitingPhase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic MelanomaThe goal of this clinical research study is to find the recommended dose of OBX-115 in combination with acetazolamide that can be given to patients with metastatic melanoma…NCT05470283·Houston, Texas

CompletedCombination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic MelanomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003027·Mobile, Alabama and 93 others

TerminatedSkin Cancer Oncology Radiation Evidence RegistryTo collect and analyze long term safety and efficacy outcomes of patients undergoing radiotherapy for non-melanoma skin cancer.NCT04681456·Fort Myers, Florida

CompletedEnsuring Communication in Hospice by Oncology Study (ECHO)The goal of this study is to determine if scheduled communication with the oncology team through phone calls is helpful to caregivers with the transition to hospice care.NCT02069769·Boston, Massachusetts

UnknownSorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant MelanomaRATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00538005·Encinitas, California

TerminatedStudy of ASN003 in Subjects With Advanced Solid TumorsThe study is divided into two parts. The first part of the study will test various doses of ASN003 to find out the highest safe dose to test in three specific groups.NCT02961283·Los Angeles, California and 4 others

UnknownVaccine Therapy in Treating Patients With Malignant MelanomaRATIONALE: Vaccines made from tumor cells may help the body build an effective immune response to kill tumor cells.NCT00128583·Palm Springs, California and 10 others

PreviousPage 15 of 167Next